Buruli ulcer

Role of specific antibiotics in Mycobacterium ulcerans (Buruli ulcer) management

Provisional guidelines


Acknowledgements

With thanks to the following for their review and constructive comments on this document:

  • Dr John Buntine, Cornell Specialists’ Centre, Victoria, Australia
  • Dr Samuel Etuaful, St Martin’s Catholic Hospital, Agroyesum, Ghana
  • Dr Christian Johnson, Buruli Ulcer Control Programme, Cotonou, Benin
  • Professor Jacques Grosset, Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
  • Professor Francoise Portaels, Department of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium
  • Dr Mark Wansbrough-Jones, Division of Infectious Disease, St. George’s Hospital Medical School, London, United Kingdom
  • Stop TB Department, HIV/AIDS, Tuberculosis, Malaria, World Health Organization, Geneva, Switzerland
Share